Small Animal Imaging (In-Vivo) Global Market Report 2022: Ukraine-Russia War Impact


NEW YORK, November 23, 2022 /PRNewswire/ —

Major players in the market include Bruker, PerkinElmer, Miltenyi Biotec, Aspect Imaging Ltd, Mediso Ltd, LI-COR Biosciences, Life Technologies Corporation, Trifoil Imaging, Promega Corporation, New England Biolabs, MR Solutions Ltd, General Electric, Sofie Biosciences Inc, Biospace Lab and Agilent Technologies Inc.

Read the full report:

The global small animal imaging (in-vivo) market is expected to grow $2.06 billion in 2021 to $2.27 billion in 2022 at a compound annual growth rate (CAGR) of 10.4%. The RussiaUkraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has resulted in economic sanctions against multiple countries, rising commodity prices and supply chain disruptions, affecting many markets around the world. The small animal imaging (in-vivo) market is expected to grow $3.38 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%.

The small animal imaging (in-vivo) market consists of the sale of small animal imaging (in-vivo) products by entities (organizations, sole proprietors and partnerships) used to observe normal and pathological processes in life , define and quantify. animal organs and tissues non-invasively. Small animal imaging (in-vivo) refers to the advanced imaging techniques for monitoring cellular activity, developed pharmacological effects, and disease progression in live animals.

The main components of small animal imaging (in-vivo) are micro-MRI, optical imaging, nuclear imaging and other components. Micro-MRI refers to a non-invasive technique that produces detailed three-dimensional (3D) images of tissues without the use of harmful radiation.

Its various applications include treatment response monitoring, biodistribution, drug-target interaction determination, cancer cell detection, biomarkers, longitudinal studies and epigenetics used in veterinary clinics, veterinary hospitals and veterinary institutes and research centers.

North America was the largest region in the small animal imaging (in-vivo) market in 2021. Europe is expected to be the fastest growing region over the forecast period.

The regions covered in the Small Animal Imaging (in vivo) market report. Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Growing spending on healthcare sector is expected to drive the growth of the small animal imaging (in vivo) market in the future. Health care expenditures refer to the total cost of health care (including public and private expenditures) as a percentage of GDP.

Rising healthcare spending and increasing healthcare awareness are encouraging the concept of self-care management, which uses PET equipment in techniques such as small animal imaging. For example, according to data released by the Organization for Economic Co-operation and Development, a Francebased on an intergovernmental economic organization, health expenditure as a percentage of GDP increased to 9.7% in OECD countries in 2020, compared to 8.8% in 2019. A group of 17 OECD countries suggests that health expenditure in 2021 continued to grow strongly at around 6%. Therefore, growing healthcare spending is driving the growth of the small animal imaging (in-vivo) market.

Technological advancement is a major trend gaining popularity in the small animal imaging (in-vivo) market. Major companies operating in the small animal imaging (in vivo) market are focusing on technological advancements to strengthen their position.

For example indoors April 2022PerkinElmer, Inc., a US-based company involved in business areas such as diagnostics, life sciences research and imaging, launched the vegan imaging system, an automated ultrasonic platform with advanced technology. The automated technology involves the use of two automated transducers, resulting in user-friendly technology and generating more consistent results to visualize the pathophysiology of the disease.

In August 2021Rigaku Corporation, a Japan-based global manufacturer and distributor of scientific and industrial instruments, primarily in x-ray and imaging technologies, has acquired MILabs BV for an undisclosed sum. With this acquisition, Rigaku expanded its global life sciences modality business by merging its original X-ray imaging business with MILabs’ animal multimodality business, including Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Optical Imaging and CT equipment ( computed tomography). MILabs BV is a Netherlands based company engaged in the development and production of molecular preclinical imaging systems such as SPECT, PET, CT and optical imaging systems used for small animal (in-vivo) imaging.

The Countries Covered in the Small Animal Imaging (In Vivo) Market Report. Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South KoreaUK, United States.

The Small Animal Imaging (in-vivo) market research report is part of a series of new reports detailing market statistics for Small Animal Imaging (in-vivo), including global small animal imaging (in-vivo) market size, regional stocks, competitors with market share for small animal imaging (in-vivo), detailed small animal imaging (in-vivo) market segments, market trends and opportunities, and any other data you may need to thrive in the small animal imaging (in-vivo) business small animal (in-vivo) industry. This Small Animal Imaging (In Vivo) Market Research Report offers a complete perspective of everything you need with an in-depth analysis of the current and future scenario of the industry.

Read the full report:

About Report Linker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data, so you get all the market research you need – instantly, in one place.

Contact Clare:
USA: (339)-368-6001
Intl: +1 339-368-6001


View original content:

SOURCE Reportlinker

You might also like